News & Updates

Show Multimedia Only
Fezolinetant reduces hot flashes during menopause

Fezolinetant reduces hot flashes during menopause

01 Aug 2022 byRoshini Claire Anthony

The neurokinin-3 receptor antagonist fezolinetant reduced the frequency and severity of menopause-associated vasomotor symptoms (VMS), according to results of the extension arm of the phase III Skylight 2 trial presented at ENDO 2022.

01 Aug 2022
Antenatal vitamin D supplementation may curb risk of infant eczema

Antenatal vitamin D supplementation may curb risk of infant eczema

01 Aug 2022 byJairia Dela Cruz

Infants born to mothers who popped vitamin D during pregnancy are less likely to develop atopic eczema compared with their counterparts whose mothers received placebo, as shown in the UK Maternal Vitamin D Osteoporosis Study (MAVIDOS).

01 Aug 2022
HBV coinfection among TB patients higher than expected

HBV coinfection among TB patients higher than expected

01 Aug 2022

Coinfection with hepatitis B virus (HBV) among patients with tuberculosis (TB) appears to be 38-percent to 450-percent more prevalent than published estimates from the Polaris group of region-specific overall HBV prevalence, suggest the results of a meta-analysis.

01 Aug 2022
Men with multiple sclerosis at risk of erectile dysfunction

Men with multiple sclerosis at risk of erectile dysfunction

01 Aug 2022

Adult men with multiple sclerosis (MS) are more likely to develop erectile dysfunction (ED), indicating that MS is a potential predictor for ED occurrence, suggest the results of a meta-analysis.

01 Aug 2022